- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01061346
Effect of Dietary Fat When Eaten With Fructose Versus Glucose (Fructose)
Effect of Dietary Fat When Eaten With Fructose vs. Glucose on Insulin Resistance and Liver Fat
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
After 2 screening visits including an exercise test, DEXA and CT scan, qualifiers begin a 7 day diet with 20% fat, 65% carbohydrate (with 20% glucose) and 15 % protein. Participants consume 2 meals per day at PBRC with lunch and weekend meals packed to go. Following a test day, participants are randomized to one of 3 diet assignments and then test again:
1)20% fat, 65% carbohydrate (with 20% glucose beverage), 15% protein 2)40% fat, 45% carbohydrate (with 20% glucose beverage), 15% protein 3)40% fat, 45% carbohydrate (with 20% fructose beverage), 15% protein On Day 7 and again 14 days later participants have labs, an oral Glucose tolerance test, hepatic and intramuscular lipid measures by MRS, vital signs and waist measurement.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Louisiana
-
Baton Rouge, Louisiana, Forenede Stater, 70808
- Pennintgon Biomedical Research Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- BMI between 25 and 35 kg/m2 inclusive
At least one of the following:
- Impaired fasting glucose between 100-125 mg/dl inclusive
- HDL below 40 mg/dl for men or below 50 mg/dl for females
- Triglycerides between 150 mg/dl and 400 mg/dl inclusive
- Blood pressure above or equal to 135 / 85 mm Hg
- Waist circumference >94cm (37 inches) for men or >80cm for women
- Mainly Healthy
Exclusion Criteria:
- Unable or unlikely to eat study foods and only foods provided by PRBC
- Taking routine medications except birth control pills
- Smoke, Abuse drugs,or Alcohol
- Pregnant or breastfeeding, irregular menstrual cycles, Post-menopausal,or PCOS
- Diabetes, heart, lung, liver, blood, or Kidney disease
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: High Fat Diet with Fructose
40% fat, 45% carbohydrate (with 20% fructose beverage), 15% protein
|
40% fat, 45% carbohydrate (with 20% fructose beverage), 15% protein
Andre navne:
|
|
Eksperimentel: High Fat Diet with Glucose
40% fat, 45% carbohydrate (with 20% glucose beverage), 15% protein
|
40% fat, 45% carbohydrate (with 20% glucose beverage), 15% protein
Andre navne:
20% fat, 65% carbohydrate (with 20% glucose beverage), 15% protein
Andre navne:
|
|
Eksperimentel: Low Fat Diet with Glucose
20% fat, 65% carbohydrate (with 20% glucose beverage), 15% protein.
|
40% fat, 45% carbohydrate (with 20% glucose beverage), 15% protein
Andre navne:
20% fat, 65% carbohydrate (with 20% glucose beverage), 15% protein
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Evidence to determine whether intake in beverages that provide 20% fructose or a similar beverage made with glucose given with a higher fat diet has an effect on your body weight, blood pressure, fats in your liver or your blood sugar.
Tidsramme: One Month
|
One Month
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: George A Bray, MD, Pennington Biomedical Research Center
- Studiestol: Sudip Bajpcyi, PhD, Pennington Biomedical Research Center
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- PBRC 29025
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Ændringer i kropsvægt
-
Kirsehir Ahi Evran UniversitesiRekrutteringBMI | Body Mass Index 25 eller højere | Body Mass Index, NormalKalkun
-
University Hospital, GenevaVBertoniMalufAktiv, ikke rekrutterendeLean Body MassSchweiz
-
Ankara Yildirim Beyazıt UniversityCyprus International UniversityAfsluttetFunktionel ydeevne | Kampsport | Body BuildingKalkun
-
CMH Lahore Medical College and Institute of DentistryLahore University of Management SciencesAfsluttetBody Mass Index, Normal | Body Mass Index 18,5 eller højerePakistan
-
University of Southern CaliforniaAfsluttetTotal Body Water AssessmentForenede Stater
-
Shanghai Zhongshan HospitalRekrutteringHigh Flow næsekanyle | Body Roundness IndexKina
-
Abcuro, Inc.Aktiv, ikke rekrutterendeInclusion Body Myositis (IBM)Forenede Stater, Australien
-
Oslo University HospitalThe Dam Foundation; The Norwegian Rheumatism AssociationAfsluttetForundersøgelse | Inclusion Body Myositis (IBM)Norge
-
Ludwig-Maximilians - University of MunichAfsluttetInclusion Body Myositis, Sporadisk | Inclusion Body Myopati, Autosomal-recessiv | Inclusion Body Myopati, Autosomal-dominant | Medfødt grå stær, ansigtsdysmorfi og neuropatiTyskland
-
University of Southern DenmarkCRI Collagen Research Institute GmbHAfsluttetKropssammensætning | Muskelstyrke | Lean Body Mass | MuskelkraftDanmark